NCT05557903 2022-09-28Phase â… Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLLLanzhou Institute of Biological Products Co., LtdPhase 1 Unknown71 enrolled
NCT00077961 2015-03-26Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHLSanofiPhase 1/2 Terminated49 enrolled
NCT00051701 2015-03-05Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's LymphomaSanofiPhase 1/2 Terminated61 enrolled